EG7 - Strong Growth but Weak Profitability in Q2
2022-09-01 08:02:00
Redeye updates its view on EG7 following its Q2-results where revenue was stronger than expected while EBITDA came in below our expectations. Looking forward, the company reiterates its guidance for 2022 albeit with a slight adjustment to profitability to reflect the divestment of Innova. On the back of lower margin assumptions, we decrease our 2022-25E EBITDA with 5-10%.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/